Treatment of thyrotoxicosis.

ISOLATION AND IDENTIFICATION OF THE LONG-ACTING THYROID STIMULATOR AND ITS RELATION TO HYPERTHYROIDISM AND CIRCUMSCRIBED PRETIBIAL MYXEDEMA. J Clin Endocrinol Metab (1964) 2.78

RISING INCIDENCE OF HYPOTHYROIDISM AFTER RADIOACTIVE-IODINE THERAPY IN THYROTOXICOSIS. N Engl J Med (1964) 2.17

Prevalence of parathyroid insufficiency after thyroidectomy. Lancet (1961) 2.09

Effects of oral and intramuscular administration of reserpine in thyrotoxicosis. N Engl J Med (1957) 2.01

Humoral factors in the pathogenesis of Graves' disease. Physiol Rev (1968) 1.98

Iodide goiter and the pharmacologic effects of excess iodide. Am J Med (1969) 1.96

Treatment of hyperthyroidism with sodium iodide I-131. JAMA (1966) 1.93

Classification of the eye changes of Grave's disease. J Clin Endocrinol Metab (1969) 1.83

Studies of peripheral thyroxine distribution in thyrotoxicosis and hypothyroidism. J Clin Invest (1968) 1.79

Iodide peroxidase in rat thyroid and salivary glands and its inhibition by antithyroid compounds. J Biol Chem (1959) 1.73

Long-term outcome of hyperthyroidism treated with antithyroid drugs. J Clin Endocrinol Metab (1966) 1.72

The use of radioactive iodine in the diagnosis and treatment of hyperthyroidism: ten years' experience. Medicine (Baltimore) (1955) 1.66

Experimental induction of tumours of the thyroid by radiation. Br Med Bull (1958) 1.62

Persistent chromosomal aberrations following radioiodine therapy for thyrotoxicosis. N Engl J Med (1966) 1.57

Effects of guanethidine on tri-iodothyronine-induced hyperthyroidism in man. N Engl J Med (1961) 1.55

Development of thyroidal suppression by triiodothyronine during six months' treatment of thyrotoxicosis with antithyroid drugs. J Clin Endocrinol Metab (1967) 1.55

NEONATAL GRAVES' DISEASE. J Clin Endocrinol Metab (1964) 1.54

Clinical trial of different doses of 131-I in treatment of thyrotoxicosis. Br Med J (1967) 1.54

PHARMACODYNAMIC EFFECTS OF BETA-ADRENERGIC RECEPTOR BLOCKADE IN PATIENTS WITH HYPERTHYROIDISM. J Clin Invest (1964) 1.53

Hypercalcemia of thyrotoxicosis. Ann Intern Med (1966) 1.52

RADIOIODINE THERAPY IN THYROTOXICOSIS; A REVIEW OF 908 CASES. Scott Med J (1964) 1.42

Thyroid acropachy. Lancet (1960) 1.40

Increased thyroid function without clinical hyperthyroidism in patients with choriocarcinoma. J Clin Endocrinol Metab (1963) 1.40

PATHOGENESIS OF THE HYPERTHYROIDISM OF GRAVES'S DISEASE. Br Med J (1965) 1.39

Survival time of circulating long-acting thyroid stimulator in neonatal thyrotoxicosis: implications for diagnosis and therapy of the disorder. Pediatrics (1965) 1.39

Autoantibodies and autoimmune diseases. JAMA (1962) 1.35

Inhibition of long-acting thyroid stimulator by thyroid particulate fractions. J Clin Invest (1966) 1.35

THE EFFECT OF IRRADIATION ON THE FUNCTION AND SURVIVAL OF RAT THYROID CELLS. Clin Sci (1965) 1.29

Studies of serum triiodothyronine concentration in maternal and cord blood: transfer of triiodothyronine across the human placenta. J Clin Endocrinol Metab (1969) 1.29

Relationship of long-acting thyroid stimulator to the clinical features and course of Graves' disease. Am J Med (1967) 1.24

CHARACTERIZATION OF THE LONG-ACTING THYROID STIMULATOR OF GRAVES' DISEASE. Proc Natl Acad Sci U S A (1964) 1.23

Thyroid-stimulating activity in the serum of rabbits immunized with thyroid microsomes. J Clin Endocrinol Metab (1968) 1.19

Evidence for the placental transfer of tri-iodothyronine in human beings. N Engl J Med (1967) 1.14

Effects of thyroid hormones on adenyl cyclase in adipose tissue and on free fatty acid mobilization. Proc Natl Acad Sci U S A (1968) 1.13

Pretibial myxoedema. Br Med J (1960) 1.12

Quantitative studies of iodine metabolism in thyroid disease. Q J Med (1962) 1.11

Human chorionic thyrotropin: further characterization and study of its secretion during pregnancy. J Clin Endocrinol Metab (1969) 1.08

Relation between long-acting thyroid stimulator and thyroid function in thyrotoxicosis. Lancet (1966) 1.08

On the immunological nature of the long acting thyroid stimulator. J Clin Endocrinol Metab (1966) 1.06

Thyroid function in subacute thyroiditis. J Clin Endocrinol Metab (1958) 1.05

Kinetic analysis of iodine metabolism. J Clin Endocrinol Metab (1966) 1.04

Incidence of leukemia following treatment of hyperthyroidism. Preliminary report of the Cooperative Thyrotoxicosis Therapy Follow-Up Study. JAMA (1968) 1.04

Remission of Graves' disease following radiotherapy of a pituitary neoplasm. Am J Med (1960) 1.04

The effect of radioactive iodine alone and in combination with methylthiouracil upon tumour production in the rat's thyroid gland. Br J Cancer (1953) 1.03

Pituitary exophthalmos; an assessment of methods of treatment. Br J Ophthalmol (1952) 1.02

THE EFFECTS OF IRRADIATION ON THE THYROID GLAND WITH PARTICULAR REFERENCE TO THE INDUCTION OF THYROID NEOPLASMS. Cancer Res (1964) 1.01

Effects of antithyroid therapy on the long-acting thyroid stimulator and the antithyroglobulin antibodies. J Clin Endocrinol Metab (1969) 1.00

The thyroid gland in pregnancy. N Engl J Med (1957) 0.99

GLUCOCORTICOID-INDUCED DISAPPEARANCE OF LONG-ACTING THYROID STIMULATOR IN THE OPHTHALMOPATHY OF GRAVES' DISEASE. J Clin Endocrinol Metab (1964) 0.98

TREATMENT OF HYPERTHYROIDISM IN CHILDREN. ANALYSIS OF FORTY-FIVE PATIENTS. N Engl J Med (1965) 0.97

Thyroid nodules occurring late after treatment of thyrotoxicosis with radioiodine. J Clin Endocrinol Metab (1962) 0.97

Chromophobe pituitary adenoma with acromegaly and TSH-induced hyperthyroidism associated with parathyroid adenoma. Acromegaly and parathyroid adenoma. Acta Endocrinol (Copenh) (1969) 0.97

The treatment of hyperthyroidism. Ann Intern Med (1966) 0.97

Untoward hematologic responses to the antithyroid compounds. Am J Med (1954) 0.96

Influence of hyperthyroidism on the effects of norepinephrine on myocardial adenyl cyclase activity and contractile state. Endocrinology (1969) 0.96

Influence of iodine intake after treatment with antithyroid drugs. Lancet (1965) 0.95

TREATMENT OF HYPERTHYROIDISM WITH A SINGLE DAILY DOSE OF PROPYLTHIOURACIL. N Engl J Med (1965) 0.95

Extraction and characterization of a thyrotropic material from the human placenta. J Clin Invest (1969) 0.95

Evaluation of radioactive iodine (I131) as a treatment for hyperthyroidism. N Engl J Med (1959) 0.95

CARCINOMA OF THE THYROID FOLLOWING TREATMENT OF HYPERTHYROIDISM WITH RADIOACTIVE IODINE. Calif Med (1964) 0.94

Influence of beta sympathetic blockade (propranolol) on the hemodynamics of hyperthyroidism. Am J Med (1969) 0.93

Radioactive iodine, antithyroid drugs, and surgery in treatment of hyperthyroidism. Arch Surg (1967) 0.93

USE OF A THYROID SUPPRESSION TEST AS A GUIDE TO PROGNOSIS OF HYPERTHYROIDISM TREATED WITH ANTITHYROID DRUGS. J Clin Endocrinol Metab (1965) 0.93

Decreased myocardial adenyl cyclase activity in hypothyroidism. J Clin Invest (1969) 0.93

The iodinated albuminlike component of the plasma of thyrotoxic patients. J Clin Endocrinol Metab (1962) 0.93

Prevalence of parathyroid insufficiency after thyroidectomy. Lancet (1963) 0.92

Radiation, thyroid cells and 131-I therapy--a hypothesis. J Clin Endocrinol Metab (1965) 0.91

Functioning metastatic carcinoma of the thyroid producing clinical hyperthyroidism. Am J Med (1960) 0.91

Neutralization of the long-acting thyroid stimulator by thyroid subcellular fractions. J Lab Clin Med (1967) 0.89

Studies of the thyroid iodide "trap" in man. Recent Prog Horm Res (1969) 0.89

Quantitative studies of iodine metabolism after long-term treatment of thyrotoxicosis with antithyroid drugs. J Clin Endocrinol Metab (1966) 0.89

Ophthalmopathy without hyperthyroidism in patients with histologic Hashimoto's thyroiditis. J Clin Endocrinol Metab (1968) 0.89

Prediction of the long-term results of antithyroid drug therapy for thyrotoxicosis. J Clin Endocrinol Metab (1969) 0.87

RESPONSES OF THE NORMAL HUMAN TO INFUSIONS OF PLASMA FROM PATIENTS WITH GRAVES' DISEASE. J Clin Invest (1965) 0.87

Adenosine 3',5'-monophosphate-dependent protein kinase from brain. Science (1969) 0.86

The long-acting thyroid stimulator: its role in Graves' disease. Recent Prog Horm Res (1967) 0.85

Hyperthyroidism during pregnancy. N Engl J Med (1965) 0.84

Interaction of purified long-acting thyroid stimulator (LATS) and thyroid microsomes in vitro. J Clin Endocrinol Metab (1969) 0.82

Thyroid-stimulating activity in the serum of immunized rabbits. II. Nature of the thyroid-stimulating material. J Clin Endocrinol Metab (1968) 0.81

Activation of cardiac adenyl cyclase by thyroid hormone. Biochem Biophys Res Commun (1968) 0.81

The effect of radioablation of the thyroid gland in Graves' disease with high levels of long-acting thyroid stimulator (LATS). Am J Med (1969) 0.80

[The problem of thyrostimulating factors. Demonstration of a human placental thyrostimulin]. Ann Endocrinol (Paris) (1966) 0.79

Fatal aplastic anemia following use of potassium perchlorate in thyrotoxicosis. JAMA (1962) 0.79

Evaluation of the relationship between long-acting thyroid stimulator, clinical and biological thyrotoxicosis and exophthalmos. Acta Endocrinol (Copenh) (1968) 0.79

Concentration and binding capacity of thyroxin-binding prealbumin in pregnancy, hyper- and hypothyroidism. Tohoku J Exp Med (1968) 0.79

Fatal aplastic anaemia after treatment of thyrotoxicosis with potassium perchlorate. Br Med J (1961) 0.78

Iodine-125 treatment for thyrotoxicosis. Lancet (1969) 0.77

Proteolytic activity and inhibition of the long-acting stimulator of Graves' disease by thyroid extracts. Biochim Biophys Acta (1967) 0.76

Comparison of early effects of thyrotropin and long-acting thyroid stimulator on thyroidal phospholipogenesis. Endocrinology (1968) 0.76

LATS and thyroid autoantibodies. Clin Exp Immunol (1968) 0.76

The long-acting thyroid stimulator. Calif Med (1968) 0.76

Studies on the immunological properties of LATS. Endocrinology (1968) 0.76

THE BI-DIRECTIONAL PLACENTAL TRANSFER OF I131 3:5:3' TRIIODOTHYRONINE IN THE RHESUS MONKEY. Pediatrics (1965) 0.76

[Thyroid-stimulating activity with prolonged action in the serum of rabbits immunized with human thyroid]. Folia Endocrinol (1965) 0.76

Stimulation of thyroid hyperplasia and protein synthesis by LATS. Endocrinology (1969) 0.76

[Influence of perchlorate and methimazole on the urinary excretion of iodine in man]. Arch Int Pharmacodyn Ther (1961) 0.76

The mechanism of thyroid hormone secretion. Ann Intern Med (1968) 0.76

Induction of neoplasms in rat thyroid glands by low doses of radio-iodine. Arch Pathol (1960) 0.76

An appraisal of the current methods of treatment of toxic goiter. Surgery (1969) 0.75

Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. J Clin Endocrinol Metab (2000) 2.68

Hormonal and genetic control of germ cell apoptosis in the testis. Rev Reprod (1999) 1.65

Testosterone replacement therapy improves mood in hypogonadal men--a clinical research center study. J Clin Endocrinol Metab (1996) 1.57

A controlled comparison of the efficacy of clomiphene citrate in male infertility. Fertil Steril (1988) 1.50

Single exposure to heat induces stage-specific germ cell apoptosis in rats: role of intratesticular testosterone on stage specificity. Endocrinology (1999) 1.47

Testicular pathologic changes and the pituitary-testicular axis during human immunodeficiency virus infection. Endocr Pract (2004) 1.40

The Prader-Willi syndrome: a study of 40 patients and a review of the literature. Medicine (Baltimore) (1983) 1.39

Simultaneous radioimmunoassay of plasma FSH, LH, progesterone, 17-hydroxyprogesterone, and estradiol-17 beta during the menstrual cycle. J Clin Endocrinol Metab (1972) 1.29

Reproductive hormonal function in the genetically obese (ob/ob) mouse. Endocrinology (1976) 1.28

Low serum testosterone and sex-hormone-binding-globulin in massively obese men. J Clin Endocrinol Metab (1977) 1.26

Male sexual function and its disorders: physiology, pathophysiology, clinical investigation, and treatment. Endocr Rev (2001) 1.25

Pharmacokinetics of transdermal testosterone gel in hypogonadal men: application of gel at one site versus four sites: a General Clinical Research Center Study. J Clin Endocrinol Metab (2000) 1.21

Sublingual testosterone replacement improves muscle mass and strength, decreases bone resorption, and increases bone formation markers in hypogonadal men--a clinical research center study. J Clin Endocrinol Metab (1996) 1.17

Serum luteinizing and follicle stimulating hormone levels during sequential and nonsequential contraceptive treatment of eugonadal women. J Clin Endocrinol Metab (1969) 1.17

Involvement of apoptosis in the induction of germ cell degeneration in adult rats after gonadotropin-releasing hormone antagonist treatment. Endocrinology (1995) 1.17

Nutritional and metabolic effects of gonadotropin-releasing hormone agonist treatment for prostate cancer. Metabolism (1990) 1.13

Neurobehavioral phenotype of Klinefelter syndrome. Ment Retard Dev Disabil Res Rev (2000) 1.11

Significance of apoptosis in the temporal and stage-specific loss of germ cells in the adult rat after gonadotropin deprivation. Biol Reprod (1997) 1.10

Testicular heat exposure enhances the suppression of spermatogenesis by testosterone in rats: the "two-hit" approach to male contraceptive development. Endocrinology (2000) 1.07

Androgen-behavior correlations in hypogonadal men and eugonadal men. II. Cognitive abilities. Horm Behav (1998) 1.07

Hormonal therapy of cryptorchidism. A randomized, double-blind study comparing human chorionic gonadotropin and gonadotropin-releasing hormone. N Engl J Med (1986) 1.07

Progestogen-induced luteinizing and follicle-stimulating hormone surge in postmenopausal women: a simulated ovulatory peak. Proc Natl Acad Sci U S A (1968) 1.06

Effects of transdermal testosterone gel on bone turnover markers and bone mineral density in hypogonadal men. Clin Endocrinol (Oxf) (2001) 1.04

The structural brain correlates of cognitive deficits in adults with Klinefelter's syndrome. J Clin Endocrinol Metab (2006) 1.03

Role of temperature in regulation of spermatogenesis and the use of heating as a method for contraception. Fertil Steril (1988) 1.01

Neuropsychological profiles of adults with Klinefelter syndrome. J Int Neuropsychol Soc (2001) 1.01

Mechanisms of gonadotropin-releasing hormone agonist action in the human male. Endocr Rev (1986) 1.00

Obesity, low testosterone levels and erectile dysfunction. Int J Impot Res (2008) 0.99

Long-term effects of triptolide on spermatogenesis, epididymal sperm function, and fertility in male rats. J Androl (2000) 0.98

Influence of immunization procedures on the titer, affinity and specificity of antisera to glycopolypeptides. Acta Endocrinol Suppl (Copenh) (1969) 0.97

Ethnic differences in testicular structure and spermatogenic potential may predispose testes of Asian men to a heightened sensitivity to steroidal contraceptives. J Androl (1998) 0.97

Androgens: risks and benefits. J Clin Endocrinol Metab (1991) 0.96

In vitro inhibition of testosterone biosynthesis by ketoconazole. Endocrinology (1985) 0.94

Serum LH and FSH during sexual maturation in the male rat: effect of castration and cryptorchidism. Endocrinology (1971) 0.93

Temporal and stage-specific changes in spermatogenesis of rat after gonadotropin deprivation by a potent gonadotropin-releasing hormone antagonist treatment. Endocrinology (1993) 0.92

Comparison of the kinetics of injectable testosterone in eugonadal and hypogonadal men. Fertil Steril (1982) 0.92

Etiologies of sexual maturation: a model system based on the sexually maturing rat. Recent Prog Horm Res (1976) 0.91

DDT homologues: estrogen-like effects on the vagina, uterus and pituitary of the rat. Endocrinology (1972) 0.91

FSH induction of sensitivity to LH: one cause of sexual maturation in the male rat. Endocrinology (1973) 0.90

Male contraception; synergism of gonadotropin-releasing hormone analog and testosterone in suppressing gonadotropin. Science (1980) 0.90

Lead toxicity and the hypothalamic-pituitary-testicular axis. Biol Reprod (1985) 0.89

Levonorgestrel implants (Norplant II) for male contraception clinical trials: combination with transdermal and injectable testosterone. J Clin Endocrinol Metab (2002) 0.89

Posttesticular antifertility action of triptolide in the male rat: evidence for severe impairment of cauda epididymal sperm ultrastructure. J Androl (2000) 0.89

The effect of sexual maturation on testicular response to LH stimulation of testosterone secretion in the intact rat. Endocrinology (1974) 0.89

Sexual function does not change when serum testosterone levels are pharmacologically varied within the normal male range. Fertil Steril (1993) 0.88

Spontaneous expression of inducible nitric oxide synthase in the hypothalamus and other brain regions of aging rats. Endocrinology (1998) 0.88

Comparative pharmacokinetics of three doses of percutaneous dihydrotestosterone gel in healthy elderly men--a clinical research center study. J Clin Endocrinol Metab (1998) 0.88

Triptolide: a potential male contraceptive. J Androl (1998) 0.88

Redistribution of Bax is an early step in an apoptotic pathway leading to germ cell death in rats, triggered by mild testicular hyperthermia. Biol Reprod (2000) 0.88

Up-regulation of the levels of androgen receptor and its mRNA by androgens in smooth-muscle cells from rat penis. Mol Cell Endocrinol (1993) 0.87

Spontaneous germ cell apoptosis in humans: evidence for ethnic differences in the susceptibility of germ cells to programmed cell death. J Clin Endocrinol Metab (1998) 0.87

Aging results in attenuated gonadotropin releasing hormone-luteinizing hormone axis responsiveness to glutamate receptor agonist N-methyl-D-aspartate. J Neuroendocrinol (1998) 0.87

XXY male mice: an experimental model for Klinefelter syndrome. Endocrinology (2001) 0.87

Hormonal mechanisms in the onset of puberty. Postgrad Med J (1975) 0.86

Reproductive aging in the Brown Norway rat is characterized by accelerated germ cell apoptosis and is not altered by luteinizing hormone replacement. J Androl (1999) 0.86

Aging-related increased expression of inducible nitric oxide synthase and cytotoxicity markers in rat hypothalamic regions associated with male reproductive function. Neuroendocrinology (2001) 0.86

Testosterone down-regulates the levels of androgen receptor mRNA in smooth muscle cells from the rat corpora cavernosa via aromatization to estrogens. J Steroid Biochem Mol Biol (1993) 0.86

Beta-adrenergic receptor and cyclic AMP alterations in the canine ventricular septum during long-term norepinephrine infusion: implications for hypertrophic cardiomyopathy. Circulation (1983) 0.85

Pituitary and gonadal hormones in patients with varicocele. Fertil Steril (1975) 0.85

Effect of in vitro ketoconazole on steroid production in rat testis. Steroids (1986) 0.85

Thyroid hormone modulation of thyrotrophin-releasing hormone (TRH) and TRH-Gly levels in the male rat reproductive system. J Endocrinol (1987) 0.85

Endocrine effects of acute and chronic cimetidine administration. Dig Dis Sci (1981) 0.84

Effect of testosterone enanthate on hematopoiesis in normal men. Fertil Steril (1983) 0.84

Radioimmunoassay of plasma 17-hydroxyprogesterone. J Clin Endocrinol Metab (1971) 0.84

Influence of age on the intravenous tolbutamide response test. Diabetes (1967) 0.83

UCLA conference. Infertility in the male. Ann Intern Med (1985) 0.83

Physiological control of puberty. Med Clin North Am (1978) 0.83

Identification and partial characterization of gonadotropin-releasing hormone-like factors in human seminal plasma. Biol Reprod (1985) 0.83

Serum triiodothyronine in undernourished rats: dependence on dietary composition rather than total calorie or protein intake. Endocrinology (1978) 0.83

Biphasic effect of testosterone on spermatogenesis in the rat. Invest Urol (1973) 0.83

Testosterone replacement ameliorates nonalcoholic fatty liver disease in castrated male rats. Endocrinology (2013) 0.83

The hypothalamic-pituitary axis in genetically obese (ob/ob) mice: response to luteinizing hormone-releasing hormone. Endocrinology (1978) 0.82

Androgen-behavior correlations in hypogonadal men and eugonadal men. I. Mood and response to auditory sexual stimuli. Horm Behav (1997) 0.82

Effects of aging on the in vitro release of gonadotropin-releasing hormone. Endocrinology (1986) 0.82

A psychiatric study of patients referred with a diagnosis of hypoglycemia. Am J Psychiatry (1976) 0.82

In the male brown-Norway (BN) male rat, reproductive aging is associated with decreased LH-pulse amplitude and area. J Androl (1997) 0.82

Developments in the control of testicular function. Baillieres Clin Endocrinol Metab (1992) 0.81

Search for a substance which selectively inhibits FSH--effects of steroids and prostaglandins on serum FSH and LH levels. Steroids (1973) 0.81

Gonadotropin therapy failure secondary to human chorionic gonadotropin-induced antibodies. J Clin Endocrinol Metab (1981) 0.81

Hormonal effects of ketoconazole in vivo in the male rat: mechanism of action. Endocrinology (1986) 0.81

Time course of recovery of spermatogenesis and Leydig cell function after cessation of gonadotropin-releasing hormone antagonist treatment in the adult rat. Endocrinology (1994) 0.81

Effect of estradiol on uterine weight, thyroid function food intake, and pituitary weight of genetically obese (fatty-Zucker) and lean rats. Proc Soc Exp Biol Med (1976) 0.81

Effect of increased scrotal temperature on sperm production in normal men. Fertil Steril (1997) 0.81

Temporal and stage-specific effects of recombinant human follicle-stimulating hormone on the maintenance of spermatogenesis in gonadotropin-releasing hormone antagonist-treated rat. Endocrinology (1995) 0.81

Dissociating antifertility effects of GnRH-antagonist from its adverse effects on mating behavior in male rats. Am J Physiol (1988) 0.80

The role of hypothalamic adrenergic receptors in preventing testosterone-induced androgenization in the female rat brain. Endocrinology (1981) 0.80

Cyproterone: effect on serum gonadotropins in the male. Endocrinology (1972) 0.80

Impairment of spermatogenesis in transgenic mice with selective overexpression of Bcl-2 in the somatic cells of the testis. J Androl (2001) 0.80

Nuclear accumulation of estradiol derived from the aromatization of testosterone is inhibited by hypothalamic beta-receptor stimulation in the neonatal female rat. Biol Reprod (1984) 0.80

Graded testosterone infusions distinguish gonadotropin negative-feedback responsiveness in Asian and white men--a Clinical Research Center study. J Clin Endocrinol Metab (1998) 0.80

A biodegradable testosterone microcapsule formulation provides uniform eugonadal levels of testosterone for 10-11 weeks in hypogonadal men. J Clin Endocrinol Metab (1992) 0.79

Reproductive function in the genetically obese "fatty" rat. Endocrinology (1973) 0.79

Effects of cyclosporine on the hypothalamic-pituitary-gonadal axis in the male rat: mechanism of action. Endocrinology (1988) 0.79

Superactive gonadotropin-releasing hormone agonists. Annu Rev Med (1983) 0.79

Androgen replacement therapy. Curr Ther Endocrinol Metab (1997) 0.79

Screening urine for exogenous testosterone by isotope ratio mass spectrometric analysis of one pregnanediol and two androstanediols. J Chromatogr B Biomed Sci Appl (1999) 0.79

Gonadotropin-releasing hormone analog and testosterone synergistically inhibit spermatogenesis. Endocrinology (1981) 0.78

Nutritional influences on sexual maturation in the rat. Fed Proc (1980) 0.78

Early effects of vasectomy on testicular structure and on germ cell and macrophage apoptosis in the hamster. J Androl (1997) 0.78

Regulation of testicular inhibin subunit messenger ribonucleic acid levels in vivo: effects of hypophysectomy and selective follicle-stimulating hormone replacement. Endocrinology (1989) 0.78